Correct Capital Wealth Management Acquires New Holdings in KindlyMD, Inc. $NAKA

Correct Capital Wealth Management bought a new stake in KindlyMD, Inc. (NASDAQ:NAKA) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 4,464,286 shares of the company’s stock, valued at approximately $111,339,000. KindlyMD comprises approximately 15.6% of Correct Capital Wealth Management’s portfolio, making the stock its biggest holding. Correct Capital Wealth Management owned about 74.13% of KindlyMD at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Truist Financial Corp bought a new position in shares of KindlyMD during the 3rd quarter valued at $12,470,000. Evergreen Capital Management LLC acquired a new position in KindlyMD during the third quarter worth $1,335,000. Almanack Investment Partners LLC. acquired a new position in KindlyMD during the third quarter worth $1,377,000. Vontobel Holding Ltd. bought a new position in KindlyMD during the third quarter valued at about $335,000. Finally, Osaic Holdings Inc. acquired a new stake in shares of KindlyMD in the second quarter worth about $215,000.

KindlyMD Stock Up 14.8%

Shares of NASDAQ NAKA opened at $0.29 on Friday. KindlyMD, Inc. has a 12 month low of $0.25 and a 12 month high of $34.77. The company has a market cap of $129.27 million, a P/E ratio of -0.26 and a beta of 31.46. The business’s 50 day moving average is $0.41 and its two-hundred day moving average is $2.69.

Wall Street Analysts Forecast Growth

NAKA has been the topic of a number of analyst reports. B. Riley Financial lowered their price objective on KindlyMD from $2.00 to $1.00 and set a “buy” rating on the stock in a report on Thursday, November 20th. Zacks Research upgraded KindlyMD to a “hold” rating in a report on Friday, October 17th. Weiss Ratings reissued a “sell (e+)” rating on shares of KindlyMD in a research report on Monday, December 29th. Finally, Wall Street Zen upgraded shares of KindlyMD to a “sell” rating in a research note on Saturday, October 18th. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $4.50.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.